
ALT One of the biggest challenges in pediatric MRI is managing motion artifacts. Sedation or anesthesia is frequently used, to minimize the motion artifacts. However, these approaches carry increased medical risks and additional costs. Motion correction techniques offer a promising solution, however, no single method has yet gained widespread clinical acceptance due to the stringent requirements for robustness, reliability, and seamless integration into clinical workflows. Data-driven retrospective motion correction offers a promising solution to these challenges. It derives the motion trajectory information from the acquired k-space data of the imaging sequence and produces the motion-corrected images without the need for additional tracking hardware or disruptive sequence modifications. Moreover, a significant advantage over prospective techniques is that radiologists can directly compare the motion-modeled reconstruction with the original, non-corrected images.

ALT Advancements in phased array ultrasound transducers, algorithms accommodating skull penetration by sound waves, and the integration of MRI for accurate targeting and thermometry result in the ability of MRgFUS to perform brain lesions with sub-millimeter precision. The remarkable targeting accuracy and incisionless nature of this modality have created a paradigm shift in the management of conditions such as chronic neuropathic pain (CNP), essential tremor, and Parkinson’s disease. Furthermore, an expanding body of clinical evidence supports the efficacy of MRgFUS ablation in treating psychiatric disorders and epilepsy. More than 350 focused MRgFUS treatments have been performed so far at the Clínica Universidad de Navarra using a 3T MAGNETOM Skyra. Read how they have honed their modus operandi and improved their results, both from an effectiveness and a safety standpoint.































